Introduction – Overview of the Novo Nordisk Foundation
The Novo Nordisk Foundation is one of the largest enterprise foundations in the world, based in Denmark. Established in 1924, the foundation supports health, life sciences, and sustainability research with the overarching goal of improving human health and societal well-being.
As an independent, non-profit foundation, the Novo Nordisk Foundation combines long-term ownership of the Novo Group companies with extensive philanthropic grant-making, making it a global leader in science-driven philanthropy.
History and Background
The Novo Nordisk Foundation has its roots in the early development of the Danish insulin industry. It was formally established in 1924 to ensure that profits from the Novo Group would be reinvested into research, innovation, and societal benefit.
Key Historical Milestones
- 1924 – Novo Nordisk Foundation established in Denmark
- 1989 – Formation of Novo Nordisk A/S following the merger of Novo Industri and Nordisk Gentofte
- 2000s – Expansion of large-scale funding for biomedical and life science research
- 2010s–present – Significant growth in funding for sustainability, bioscience infrastructure, and global health
Over time, the foundation has evolved into one of the world’s most influential science and health research funders.
Mission and Purpose
The mission of the Novo Nordisk Foundation is to advance knowledge and improve people’s health through research and innovation.
Core Objectives
- Support excellent basic and translational research in health and life sciences
- Promote innovation in diabetes, metabolic diseases, and biotechnology
- Strengthen scientific ecosystems and research infrastructure
- Advance sustainability and planetary health
- Foster talent development and international collaboration
The foundation takes a long-term, strategic approach, focusing on areas where science can deliver the greatest societal impact.
Governance and Structure
The Novo Nordisk Foundation operates as an enterprise foundation under Danish law.
Governance Features
- Governed by an independent Board of Directors
- Majority owner of Novo Nordisk A/S and Novonesis
- Clear separation between commercial activities and grant-making decisions
- Strong commitment to transparency, ethics, and scientific integrity
This structure allows the foundation to ensure both financial sustainability and independent philanthropic action.
Funding and Grants
The Novo Nordisk Foundation is a major provider of research grants and strategic funding at national and international levels.
Types of Grants and Support
- Open competition grants for independent basic research
- Strategic grants aligned with foundation priority areas
- Funding for research infrastructure and large-scale facilities
- Support for interdisciplinary research centers
- Grants for conferences, science communication, and talent development
Funding is primarily awarded to universities, research institutions, and scientific organizations.
Major Programs and Initiatives
Health and Life Sciences Research
- Diabetes, obesity, cardiovascular, and metabolic disease research
- Biotechnology and biomedical innovation
Interdisciplinary Research Centers
- Establishment of world-class research centers in Denmark and internationally
- Collaboration across disciplines such as biology, medicine, data science, and engineering
Sustainability and Biosolutions
- Research on sustainable food systems, climate solutions, and planetary health
- Support for green technologies and bioscience innovation
Talent and Capacity Building
- Fellowships for early-career and senior researchers
- International mobility and collaboration programs
Impact and Examples of Work Funded
The Novo Nordisk Foundation has made a transformative impact on global science and health:
- Billions of euros invested in health and life sciences research
- Establishment of cutting-edge research centers and laboratories
- Major contributions to diabetes research and treatment innovation
- Strengthening Denmark’s position as a global life sciences hub
- Advancing sustainability research with global relevance
The foundation’s funding has enabled breakthroughs that benefit patients, researchers, and society at large.
Conclusion
The Novo Nordisk Foundation is a global leader in science-based philanthropy, uniquely combining enterprise ownership with large-scale grant-making. Through sustained investment in research, innovation, and sustainability, the foundation plays a critical role in advancing health and addressing complex global challenges.
Its long-term vision, strong governance, and commitment to excellence ensure lasting impact for future generations.
For more information, visit here.
